1.
Gynecol Oncol Rep
; 37: 100817, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34258357
RESUMO
â¢Checkpoint inhibitor therapy affecting PD-L1 as treatment for advanced solid tumors.â¢Success in trial pembrolizumab therapy in multiresistant metastatic choriocarcinoma.â¢Long-term remission after pembrolizumab therapy in multiresistant choriocarcinoma.â¢Only six reported cases, one with comparable follow-up and outcome.
2.